Drug
Arm B Vinorelbine Capecitabine
Arm B Vinorelbine Capecitabine: highest development phase Phase 2, developed by Pierre Fabre. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Pierre Fabre
Trials
| Drug | Phase | Indication |
|---|---|---|
| Arm B Vinorelbine (Navelbine oral) Capecitabine (Xeloda) NCT01941771 | Phase 2 | Breast Cancer |
Latest
No recent events.
Follow Arm B Vinorelbine Capecitabine on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.